MKI67 and breast carcinoma: Chen [21] and Ács [22] found that higher Ki-67 positivity prior to NAC treatment was predictive of pCR in breast cancer patients, but such elevated Ki-67 expression is also associated with a worse patient prognosis, such that Ki-67-high patients who do not respond to NAC generally have poor outcomes.